作者: Stanislas Pol
DOI: 10.1038/NRGASTRO.2012.164
关键词:
摘要: As new therapeutics are emerging for the treatment of patients with HCV, nomenclature defining virologic response is becoming outdated, leading to inconsistencies and confusion. A recent paper has attempted devise a that will be able respond future advances in HCV therapy.